Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MiracLens is a private ophthalmology and vision care company focused on orthokeratology (Ortho-K) for myopia management and non-surgical vision correction. The company markets practitioner-guided overnight corneal reshaping contact lens systems, including its M-Series design, and provides an online Virtual Lens Designer that allows eye care professionals to customize lenses without requiring corneal topography. MiracLens positions itself as both a product and clinical support organization for doctors performing Ortho-K. Its products are used to manage childhood myopia and other refractive errors through rigid gas permeable lens-based vision shaping treatment. The business appears to be commercially active and operates as a niche eye care device company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MiracLens.